Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00861653 · ClinicalTrials.gov registry record

Atherosclerotic Plaque Characterization

A clinical trial, sponsored by Piedmont Healthcare.

Completed
Registry status
50
Enrollment target

NCT00861653 is a clinical trial that has completed, run by Piedmont Healthcare. The registered enrollment target is 50 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00861653 has completed, sponsored by Piedmont Healthcare.

COMPLETED
Registry status
50 participants
Enrollment target

Study Summary

The purpose of this study is to utilize high-resolution CMR carotid imaging for the characterization of carotid wall volumes and plaque content in patients with clinical significant carotid atherosclerosis. Patients who are scheduled to undergo an imaging procedure will be recruited from the cath lab. Upon enrollment, blood samples conventional and genetic profiling will be collected. For patients undergoing a carotid endarterectomy, tissue from the carotid vessel will be collected during their procedure. Comparison of the MR images with tissue and/or blood samples will be made. Length of time in the study will be approximately 1 day. There will be no study-related patient follow-up.

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2006-10
Est. Completion 2013-07

Sponsor

Piedmont Healthcare

13 total trials

What the Registry Record Tells You About NCT00861653

The ClinicalTrials.gov registry entry for NCT00861653 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Piedmont Healthcare, which has 13 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT00861653 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00861653 about?

NCT00861653 is a clinical study titled "Atherosclerotic Plaque Characterization". The purpose of this study is to utilize high-resolution CMR carotid imaging for the characterization of carotid wall volumes and plaque content in patients with clinical significant carotid atherosclerosis. Patients who are scheduled to undergo an imaging procedure will be recruited from the cath la...

What is the current status of trial NCT00861653?

This trial is currently completed. The enrollment target is 50 participants. The study started on 2006-10. Estimated completion is 2013-07.

Who is sponsoring clinical trial NCT00861653?

This trial is sponsored by Piedmont Healthcare, which has 13 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.